SUSAN HUDSON: Open Payments
NPI 1396390480 · BOULDER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,455 in 64 payments from 15 companies in 2025. Trend: 2023 $238 · 2024 $861 · 2025 $1,455
Food & beverage: $1,455
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $242 |
| Alkermes, Inc. | 6 | $241 |
| Collegium Pharmaceutical, Inc. | 5 | $186 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $96 |
| Axsome Therapeutics, Inc. | 3 | $94 |
| Corium, LLC | 4 | $79 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Supernus Pharmaceuticals, Inc. | 4 | $72 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
Products named: VRAYLAR, Jornay PM, CAPLYTA, LYBALVI, REXULTI, TRINTELLIX, Auvelity, ARISTADA.
Industry payments across CO — which companies pay providers there.
